Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of decitabine in treating
patients with myelodysplastic syndromes or acute myeloid leukemia. Drugs used in chemotherapy
use different ways to stop cancer cells from dividing so they stop growing or die.